As a result of tremendous positive response to the RCCX Theory:
Karen Herbst MD PhD (Endocrinology) and I have set up a non-profit corporation to fund research investigating the possible role of the RCCX Module in familial chronic illness clusters (Ehlers-Danlos Hypermobility Type, Chronic Fatigue Syndrome, Fibromyalgia, Chronic Lyme, Mast Cell Activation Syndrome, Postural Orthostatic Tachycardia Syndrome, Pain Syndromes, Psychiatric Spectrum Disorder (including PTSD, Anxiety Disorders, Autism Spectrum Disorder, Bipolar Disorder, Psychosis, Depression, ADHD), Autoimmune/Immunological Disorders, Endocrine disorders,Subcutaneous Adipose Tissue Disorders and Neurological Conditions (Including raised Intracranial Pressure, Chiari, Chronic Migraine, etc.), etc.).
We will be gathering a large amount of family and clinical data from people with chronic illness (CFS, chronic Lyme, FM, etc), hypermobility, the CAPS profile, CYP21A2 mutations and subcutaneous adipose tissue disorders and will compare with normal controls. We are trying to track down geneticists and other collaborators to assist us with phase 2.
Should we have money left over, we will donate to the Open Medicine Foundation to assist Ron Davis PhD et al. in their pursuit of the cause and treatment of CFS/ME (which we are quite sure will eventually lead to the RCCX module).